Moreover, various tau related biomarkers have been explored more thoroughly in Alzheimer's disease [127], while many non-AD tauopathies still don’t have commonly accepted tau related biomarkers [128, 129]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.